Background: Previous research has emphasized the importance of eosinophils in
| INTRODUCTION
Inflammatory cells, such as neutrophils and eosinophils, are found in the airways and lungs of asthmatic patients. They contribute to chronic inflammation, airway obstruction, and airway hyperresponsiveness. 1 Previous research has emphasized the importance of eosinophils in allergic asthma, with less attention being devoted to neutrophils. The latter has been easy to overlook, as they are present in the lung at all times, even when the asthmatic patients seem to have no symptoms. 2 Nevertheless, neutrophils have been shown to increase in number in the lung upon viral infections, 3 colonization of bacteria, 4 and in uncontrolled asthma. 5 A recent study by Pillay et al identified that neutrophils can be subdivided into three subsets, based on their expression of CD16 and CD62L, each subset representing a different stage of maturity and activity. The CD16 dim CD62L high subset is considered the immature neutrophil, recently released from the bone marrow. These neutrophils are not found in the circulation in healthy donors, but appear 180 minutes after an LPS injection to the blood and are even more pronounced in severely injured patients. The CD16 high CD62L high -expressing neutrophils are mature, but non-activated, whereas the CD16 high CD62L dim -expressing neutrophils are considered to be mature and activated, playing an important role in inflammatory diseases such as systemic inflammation. 6 Subsets of neutrophils with similar antigen presentation characteristics have been produced in vitro using LPS and we have shown that these subsets have specific roles in allergic rhinitis 7 and head and neck squamous cells cancer. 8 Bradykinin has been proposed as a sensitive indicator for AHR, 9, 10 found to be increased in bronchoalveolar lavage (BAL) fluid from asthmatic patients as a result of allergen challenge. 11 In the presented paper, we have investigated the role of activated neutrophils, produced by LPS in vitro stimulation, on Bradykinin-induced AHR.
2 | ME TH ODS to the activation and co-culture set-up in one experiment. The supernatants from these experiments were saved in −80 prior to ELISA.
To confirm the establishment of the correct population and the purity of neutrophils (94%-97%), the cells were analysed with flow cytometry.
In order to further compare our in vitro subsets with the in vivo subsets of Pillay et al, 6 an expanded panels of antigens were investigated focusing on CD11b, CD11c, CD66b, CD49d, CD64, and CD95. As presented in Table S1 , the present neutrophil subgroups appeared in this aspect to be similar with the subsets of Pillay et al. 
| Immunohistochemistry on isolated murine tissue
Tracheal rings were cut into 5 μm thick sections using a microtome.
Sections were deparaffinized in ultraclear (5 min × 2) and rehydrated in 99.5%, 95%, and 70% EtOH followed by dH 2 0. Antigen retrieval was performed with warm citrate buffer for 25 min. Sections were then incubated with 1% Triton-X100 in PBS to permeabilize the tis- with a Nikon Digital Sight DS-U1 camera, coupled to a Nikon Eclipse TE2000-U microscope, using NIS Elements F. 2.20 software. For analysis, images were initially deconvoluted to separate the DAB and haematoxylin channels. The DAB channel was thresholded to a constant value for all pictures, and the total area of staining measured. 
| Antibodies and flow cytometry

| Statistical analysis
Statistical analyses were performed using GraphPad Prism software (version 6.0, Graph Pad Software, La Jolla, CA, USA). All data are
shown as mean ± SEM. A P-value of <0.05 was considered statistically significant (*P < 0.05, **P < 0.01, ***P < 0.001 3 | RESULTS
| In vitro activation of neutrophils from healthy volunteers
After the neutrophils were purified, they were activated with LPS and stained with antibodies to ensure the right subset prior to further experimentation (Figure 1 ). Further, flow cytometric analysis of these subgroups revealed CD16 high CD62L dim neutrophils increased the expression of CD11b, CD11c, and CD66b compared with CD16 high CD62L high neutrophils and no difference could be demonstrated on the CD49d, CD95, or CD64 expressions (Table S1 ). Pretreatment with fluticasone did not inhibit the activation of neutrophils. After 2 h of LPS, the percentage of activated neutrophils reached 97% with fluticasone treatment, and 99% without fluticasone treatment.
| Myograph measurements of neutrophiltreated airways
Different subsets of neutrophils were co-cultured with isolated airways from man and mouse, and subsequent effects on the airway smooth muscle were evaluated in myographs. The CD16 Figure 3A) . Further, presence of CD16 high CD62L dim neutrophils during the culture period increased the immunohistostaining of the bradykinin B2 receptor; no such amplification was seen neither in the controls (P = 0.004) nor when CD16 high CD62L high neutrophils were added (P = 0.03, Figure 3B ).
| IL-1β and TNFα secretion from CD16
high CD62L dim neutrophils
The supernatants from the murine co-culture were analysed with ELISA to measure IL-1β and TNFα. The CD16 high CD62L dim neutrophils produced significantly more IL-1β (P = 0.002) and TNF-α (P = 0.008) than the CD16 high CD62L high neutrophils ( Figure. 4A,B) .
When the IL-1 receptor antagonist (IL-1RA) was added to co-culture in two concentrations, the higher concentration (1 mg/mL) inhibited the TNF-α production (P = 0.047, Figure 4B ), whereas the lower concentration (0.1 mg/mL), despite being numerically reduced, showed no significant decrease. Blocking TNF-α with Etanercept resulted in a 53% inhibition of the bradykinin-induced airway contraction in mice (P = 0.04, Figure 4C ). IL-1Ra was also used in an attempt to block IL-1β response on the smooth muscle. The use of IL-1Ra on the smooth muscle neither affected the response induced by the CD16 high CD62L dim neutrophils nor the smooth muscle by itself ( Figure 5 ).
| DISCUSSION
This study details that CD16 high CD62L dim neutrophils have the ability to directly enhance the smooth muscle response to bradykinin in both human isolated small airways and murine tracheae (Figure 6 ).
F I G U R E 2 Neutrophils stimulated airways and airway contraction. (A) Isolated human airways segments (n = 7) and (B) isolated murine airway segments (n = 8-10) were cultured for 24 h and then incubated for 2 h with newly purified, inactivated neutrophils (■), activated neutrophils (•), or control vehicle (▲). The segments were then rinsed and the contractile response to KCl and bradykinin tested. Exposure to activated neutrophils caused a long-standing hyperactive response to bradykinin. All results are expressed in mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *P < 0.05, **P < 0.01 
Bradykinin is a potent pro-inflammatory peptide that is increased in broncho alveolar lavage fluid from allergen challenged asthmatic patients. 11 It limits the local airway flow in asthmatic patients through bradykinin B2 receptor mediated smooth muscle contraction. No such contraction can be induced in healthy controls. 12 Thus, bradykinin has been suggested as a more sensitive marker for airway hyperreactivity than methacholine. 9, 10 To assess the potential relationship between various neutrophil subsets and asthmatic hyperactivity, neutrophil subsets were co-cultured with murine trachea, and bradykinin-induced smooth muscle contractions were evaluated in myographs. CD16 high CD62L dim neutrophils were found to enhance the airway response to bradykinin. No corresponding effect was found using the CD16 high CD62L high neutrophils. Using a limited number of human isolated small airways, this effect could be confirmed in man, suggesting that CD16 high CD62L dim neutrophils have the ability to alter the reactivity of the airways, potentially restricting the expiratory airflow in asthmatic lungs.
It is important to notice that the present approach to induce neutrophil subgroups is not exactly the same as the one used by Pillay et al. 6 We used an in vitro set up where LPS was added to have made what appears to be a good attempt to mimic them. So albeit there is a slight difference in the methodology, the end product in terms of active CD16 high CD62L dim neutrophils seems to be very similar.
To investigate the mechanisms behind the described neutrophilinduced local airway smooth muscle hyperreactivity, isolated tracheal tissues were co-cultured with different neutrophil subsets and the supernatants were analysed. The CD16 high CD62L dim neutrophils were found to produce more IL-1β and TNF-α than CD16 high CD62L high neutrophils. The addition of an IL-1 receptor antagonist (IL-1Ra) during this procedure resulted in the inhibition of the TNF-α production, thus confirming that IL-1β enhances the secretion of TNFα from neutrophils. However, IL-1β and IL-Ra had no effect on the smooth muscle. Further, an anti-TNFα antibody, Etanercept, reduced the bradykinin response in the myograph set up. The tentative roles of IL-1β and TNFα suggested by these experiments are well in line with previous reports about the role of these cytokines in the development of smooth muscle hypersensitivity towards bradykinin. 13 18 With the advent of phenotyping and cluster analysis, the "one size fits all" approach to asthma treatment has been questioned 19 and a large subgroup of patients with severe steroid-insensitive asthma has been identified to be in need of novel treatment opportunities. As corticosteroids do not affect neutrophils and oral corticosteroids have even been shown to induce neutrophil recruitment into the airways of patients F I G U R E 5 IL-1β had no effect on the upregulated bradykinin response. Control tissues, n = 4 (π) and tissues exposed to CD16 
